Urology Center of Englewood

Bladder Cancer Advocacy Network Announces 2019 Bladder Cancer Research Innovation Awardee

(July 8, 2019, Bethesda, MD) Today, the Bladder Cancer
Advocacy Network (BCAN) announced the recipient of its prestigious Bladder
Cancer Research Innovation Award.  This
year’s awardee is Philip Beachy, Ph.D., Professor of Urology and of
Developmental Biology at the Stanford University School of Medicine. His
research project will address the need for better treatments for recurrent bladder
cancer CIS (carcinoma in-situ) and intermediate and high-risk non-muscle
invasive bladder cancer (NMIBC).

BCAN’s Bladder Cancer Research Innovation Award, funded at
$300,000 for two years, supports exceptionally novel and creative projects with
great potential to produce breakthroughs in the management of bladder cancer. 

“It is gratifying to provide funding for innovative bladder
cancer research projects such as Dr. Beachy’s. This award supports research
that is high-risk and has the potential for high-reward in new discoveries,”
said Andrea Maddox Smith, CEO of the Bladder Cancer Advocacy Network.  “These critical projects are not likely to be
funded elsewhere.  We are proud to continue
to encourage innovation in the bladder cancer research community.”

Dr. Beachy’s project is titled “Transdifferentiation of
fibroblasts to urothelial progenitors for definitive urothelial replacement
therapy in non-muscle invasive bladder cancer.” 
Dr. Beachy’s approach involves replacing the diseased urothelium with
healthy bladder urothelial progenitor cells.  In addition to generating these bladder
urothelial progenitors, he will also focus on developing methods for
transplanting these cells into bladders afflicted with NMIBC using a carcinogen-based
bladder cancer mouse model.  Dr. Beachy
intends to develop a diagnostic tool based on single-cell RNA sequencing of
human patient samples to identify candidates for this potential therapy. 

Dr. Beachy is an Ernest and Amelia Gallo Professor at the Stanford
School of Medicine in Palo Alto, California, and an Associate at Stanford’s
Institute of Stem Cell Biology and Regenerative Medicine. 

The Bladder Cancer
Advocacy Network’s (BCAN’s) mission is to increase public awareness about
bladder cancer, advance bladder cancer research and, provide educational and
support services for the bladder cancer community.

Contact:  Mark Story
Director of Communications and Marketing

Copyright © 2019 CancerConsultants. All Rights Reserved.